Health Catalyst (NASDAQ:HCAT) Rating Lowered to Neutral at BTIG Research

BTIG Research downgraded shares of Health Catalyst (NASDAQ:HCAT - Free Report) from a buy rating to a neutral rating in a research report report published on Tuesday morning, MarketBeat Ratings reports.

A number of other equities research analysts also recently weighed in on HCAT. Stephens reduced their price target on shares of Health Catalyst from $7.00 to $5.00 and set an "equal weight" rating on the stock in a research note on Thursday, March 6th. Stifel Nicolaus raised their target price on shares of Health Catalyst from $5.00 to $5.50 and gave the company a "hold" rating in a research report on Thursday, May 8th. Canaccord Genuity Group decreased their target price on shares of Health Catalyst from $10.00 to $9.00 and set a "buy" rating on the stock in a research note on Thursday, May 8th. Royal Bank Of Canada dropped their price target on Health Catalyst from $7.00 to $6.00 and set a "sector perform" rating for the company in a research note on Thursday, February 27th. Finally, Evercore ISI lowered Health Catalyst from an "outperform" rating to an "inline" rating in a research report on Wednesday, April 9th. Four research analysts have rated the stock with a hold rating and seven have given a buy rating to the company's stock. According to data from MarketBeat.com, Health Catalyst has an average rating of "Moderate Buy" and an average price target of $8.00.

Health Catalyst Price Performance

Shares of HCAT stock traded down $0.05 on Tuesday, hitting $3.60. 799,480 shares of the company's stock were exchanged, compared to its average volume of 607,234. The company has a debt-to-equity ratio of 0.40, a current ratio of 1.24 and a quick ratio of 1.24. Health Catalyst has a 12 month low of $3.49 and a 12 month high of $9.24. The stock has a market cap of $250.56 million, a P/E ratio of -3.13 and a beta of 1.53. The company has a 50 day moving average of $3.92 and a 200 day moving average of $5.09.

Institutional Investors Weigh In On Health Catalyst

A number of institutional investors have recently modified their holdings of the company. Quantbot Technologies LP bought a new position in Health Catalyst during the fourth quarter worth $29,000. Group One Trading LLC grew its holdings in Health Catalyst by 107.6% during the 4th quarter. Group One Trading LLC now owns 4,360 shares of the company's stock worth $31,000 after acquiring an additional 2,260 shares during the period. Focus Partners Wealth bought a new position in shares of Health Catalyst in the 1st quarter worth about $46,000. XTX Topco Ltd acquired a new position in shares of Health Catalyst in the 1st quarter valued at about $54,000. Finally, Aquatic Capital Management LLC acquired a new position in shares of Health Catalyst in the 4th quarter valued at about $63,000. 85.00% of the stock is owned by institutional investors.

About Health Catalyst

Health Catalyst, Inc provides data and analytics technology and services to healthcare organizations in the United States. It operates in two segments, Technology and Professional Services. The company provides data operating system data platform which provides clients single comprehensive environment to integrate and organize data from their disparate software systems; and analytics applications, a software analytics applications build for data platform to analyze clients face across clinical and quality, population health, and financial and operational use cases.